<DOC>
	<DOCNO>NCT01871493</DOCNO>
	<brief_summary>The main purpose study evaluate body absorbs remove LY2605541 , insulin lispro , mixture blood . The study two part . Participants may enroll one part . Each part four treatment period fix order . The study last approximately 8 week , include screen . Screening require within 28 day prior start study .</brief_summary>
	<brief_title>A Study LY2605541 Insulin Lispro Mixture Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<criteria>Are childbearing potential Have body mass index ( BMI ) 18 29.9 kilogram per meter square ( kg/m^2 ) , inclusive Are nonsmoker smoke least 2 month prior enter study Have know allergy insulin excipients , relate drug , history relevant allergic reaction origin Have history firstdegree relative know diabetes mellitus Have use systemic glucocorticoid within 3 month prior entry study Have donate blood blood loss 450 milliliter ( mL ) within 1 month prior study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>